Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BiomX Inc. (PHGE)
|
Add to portfolio |
|
|
|
| Price: |
$1.63
| | Metrics |
| OS: |
46.0
|
M
| |
|
|
| Market cap: |
$74.9
|
M
| |
|
|
|
Net cash:
|
$7.35
|
M
| |
$0.16
|
per share
|
|
EV:
|
$67.6
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Jun-30-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 48.2 | 27.7 | 6.3 | 0.0 | 4.7 | 9.2 | 2.4 |
| Revenue growth | 74.3% | 341.2% | 33.7% | | -49.3% | 287.1% | |
| Cost of goods sold | 0.0 | 2.8 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 |
| Gross profit | 48.2 | 24.9 | 6.3 | -0.4 | 4.7 | 9.2 | 2.4 |
| Gross margin | 100.0% | 90.0% | 100.0% | | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | | | | 0.0 | | | |
| Research and development | | 38.8 | 13.5 | | 9.1 | | |
| General and administrative | 11.3 | 9.5 | 9.2 | 0.0 | 3.7 | 2.5 | 0.6 |
| EBITA | 37.0 | -28.7 | -23.9 | -0.4 | -12.3 | 6.7 | 1.8 |
| EBITA margin | 76.6% | -103.8% | -380.1% | | -261.5% | 72.6% | 74.0% |
| Amortization of intangibles | 1.5 | 1.5 | | | | | |
| EBIT | 35.5 | -30.3 | -23.9 | -0.4 | -12.3 | 6.7 | 1.8 |
| EBIT margin | 73.5% | -109.3% | -380.1% | | -261.5% | 72.6% | 74.0% |
| Pre-tax income | 36.2 | 30.1 | 20.6 | 0.5 | 12.7 | 6.4 | 1.9 |
| Income taxes | -0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 28.0% | 0.0% | 0.0% | 0.0% |
| Net income | 36.2 | 30.1 | 20.6 | 0.3 | 12.7 | 6.4 | 1.9 |
| Net margin | 75.1% | 108.7% | 327.7% | | 271.0% | 69.6% | 79.5% |
| |
| Diluted EPS | $1.39 | $1.30 | $3.66 | $0.17 | $6.35 | | |
| Shares outstanding (diluted) | 26.0 | 23.1 | 5.6 | 2.0 | 2.0 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|